| 產(chǎn)品名稱 | LY 2955303 dihydrochloride |
| 產(chǎn)品貨號 | Axon 2637 CAS [N.A.] MF C36H42N4O3.2HClMW 651.67 Purity: 99% Soluble in DMSO Description Potent and selective retinoic acid receptor gamma (RARγ) antagonist (Ki values >1700 nM, >2980 nM, and 1.1 nM for RARα, RARβ, and RARγ, respectively) for the treatment of osteoarthritis joint pain. KEYWORDS: LY 2955303 dihydrochloride | supplier | RARγ antagonist | LY2955303 diHCl | LY-2955303 dihydrochloride | CAS [N.A.] | [1433497-19-8] | Retinoic Acid | Retinoic Acid (RAR) | Nuclear receptors | NR1B | osteoarthritis | pain | Antagonist | Receptors |
| 產(chǎn)品價(jià)格 | 現(xiàn)貨詢價(jià)，電話：010-67529703 |
| 產(chǎn)品規(guī)格 | |
| 產(chǎn)品品牌 | axonmedchem |
| 產(chǎn)品概述 | |
| 產(chǎn)品詳情 |
LY 2955303 dihydrochlorideAxon 2637 CAS [N.A.] MF C36H42N4O3.2HCl
DescriptionPotent and selective retinoic acid receptor gamma (RARγ) antagonist (Ki values >1700 nM, >2980 nM, and 1.1 nM for RARα, RARβ, and RARγ, respectively) for the treatment of osteoarthritis joint pain. KEYWORDS: LY 2955303 dihydrochloride | supplier | RARγ antagonist | LY2955303 diHCl | LY-2955303 dihydrochloride | CAS [N.A.] | [1433497-19-8] | Retinoic Acid | Retinoic Acid (RAR) | Nuclear receptors | NR1B | osteoarthritis | pain | Antagonist | Receptors
Potent and selective RARγ antagonist for the treatment of osteoarthritis pain
Chemical name4-(5-(3,5-ditert-butylphenyl)-1-(4-(4-methylpiperazine-1-carbonyl)phenyl)-1H-pyrazol-3-yl)benzoic acid dihydrochloride Parent CAS No.[1433497-19-8] |
| 產(chǎn)品資料 |
